RDS have created a blog page to give up-to-date advice on research activity affected during COVID-19.
Each working day the advice will be updated, which will include official notifications from funders, RDS operations during the quarantine, delays to the REF, ethics, and any other useful information. The date of the latest updates from the funders will be shown against each funder name. This will only show the major funders that BU applies to.
Today’s (1/4) update includes:
- a dedicated Corona Platform from the European Commission on its Funding & Tenders Portal to make information related to the COVID-19 outbreak and its impact on Horizon 2020 grants available in a single place;
- registration details for a one hour UKRO webinar to be held on 3/4 to give you the latest information in relation to funding;
- an update in the clinical guidance to researchers section with regard to Undergraduate and Master’s student research;
- and an update from the Royal Society, who have also created a dedicated page for applicants and award holders. They have also drawn together a list of their resources, activities and videos that could be used to support home learning in science, technology, engineering and maths whilst schools are closed.
Please click here for further information.
RDS advice to academics during Covid-19
RDS advice to academics during COVID-19
Research in the NHS during the COVID-19 pandemic – HRA update
UKRO Webinar: COVID-19 and EU Funding Update – 3/4/20










BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
Festival of Social Science: Introducing drowning prevention in Bangladesh
BU PhD student attending HIV conference on scholarship
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease